nodes	percent_of_prediction	percent_of_DWPC	metapath
MACITENTAN—CYP2C19—Methazolamide—glaucoma	0.112	0.205	CbGbCtD
MACITENTAN—CYP2C19—Timolol—glaucoma	0.0954	0.174	CbGbCtD
MACITENTAN—CYP3A4—Pilocarpine—glaucoma	0.0803	0.146	CbGbCtD
MACITENTAN—CYP3A4—Brinzolamide—glaucoma	0.063	0.115	CbGbCtD
MACITENTAN—CYP3A4—Dorzolamide—glaucoma	0.0609	0.111	CbGbCtD
MACITENTAN—CYP3A4—Methazolamide—glaucoma	0.0542	0.0989	CbGbCtD
MACITENTAN—CYP3A4—Acetazolamide—glaucoma	0.0434	0.079	CbGbCtD
MACITENTAN—CYP3A4—Clonidine—glaucoma	0.0392	0.0715	CbGbCtD
MACITENTAN—Bronchitis—Metipranolol—glaucoma	0.00561	0.0236	CcSEcCtD
MACITENTAN—Bronchitis—Latanoprost—glaucoma	0.00456	0.0192	CcSEcCtD
MACITENTAN—Urinary tract infection—Latanoprost—glaucoma	0.00411	0.0173	CcSEcCtD
MACITENTAN—Nasopharyngitis—Apraclonidine—glaucoma	0.00392	0.0165	CcSEcCtD
MACITENTAN—Nasopharyngitis—Bimatoprost—glaucoma	0.0038	0.016	CcSEcCtD
MACITENTAN—Bronchitis—Bimatoprost—glaucoma	0.00353	0.0149	CcSEcCtD
MACITENTAN—Infestation NOS—Apraclonidine—glaucoma	0.00338	0.0142	CcSEcCtD
MACITENTAN—Infestation—Apraclonidine—glaucoma	0.00338	0.0142	CcSEcCtD
MACITENTAN—Nasopharyngitis—Brimonidine—glaucoma	0.00336	0.0142	CcSEcCtD
MACITENTAN—Oedema—Metipranolol—glaucoma	0.00332	0.014	CcSEcCtD
MACITENTAN—Influenza—Brimonidine—glaucoma	0.00325	0.0137	CcSEcCtD
MACITENTAN—Nasopharyngitis—Brinzolamide—glaucoma	0.00316	0.0133	CcSEcCtD
MACITENTAN—Bronchitis—Brimonidine—glaucoma	0.00313	0.0132	CcSEcCtD
MACITENTAN—Influenza—Dorzolamide—glaucoma	0.00311	0.0131	CcSEcCtD
MACITENTAN—Influenza—Travoprost—glaucoma	0.00309	0.013	CcSEcCtD
MACITENTAN—Oedema—Carteolol—glaucoma	0.00307	0.0129	CcSEcCtD
MACITENTAN—Pharyngitis—Apraclonidine—glaucoma	0.00301	0.0127	CcSEcCtD
MACITENTAN—Bronchitis—Dorzolamide—glaucoma	0.00299	0.0126	CcSEcCtD
MACITENTAN—Bronchitis—Travoprost—glaucoma	0.00297	0.0125	CcSEcCtD
MACITENTAN—Bronchitis—Brinzolamide—glaucoma	0.00294	0.0124	CcSEcCtD
MACITENTAN—Influenza—Pilocarpine—glaucoma	0.00293	0.0124	CcSEcCtD
MACITENTAN—Infection—Carbachol—glaucoma	0.00293	0.0123	CcSEcCtD
MACITENTAN—Pharyngitis—Bimatoprost—glaucoma	0.00292	0.0123	CcSEcCtD
MACITENTAN—Hypotension—Carteolol—glaucoma	0.00287	0.0121	CcSEcCtD
MACITENTAN—Bronchitis—Pilocarpine—glaucoma	0.00282	0.0119	CcSEcCtD
MACITENTAN—Infestation NOS—Travoprost—glaucoma	0.00276	0.0116	CcSEcCtD
MACITENTAN—Infestation—Travoprost—glaucoma	0.00276	0.0116	CcSEcCtD
MACITENTAN—Hypotension—Carbachol—glaucoma	0.00276	0.0116	CcSEcCtD
MACITENTAN—Angiopathy—Apraclonidine—glaucoma	0.00275	0.0116	CcSEcCtD
MACITENTAN—Infestation NOS—Brinzolamide—glaucoma	0.00272	0.0115	CcSEcCtD
MACITENTAN—Infestation—Brinzolamide—glaucoma	0.00272	0.0115	CcSEcCtD
MACITENTAN—Hypotension—Levobunolol—glaucoma	0.00271	0.0114	CcSEcCtD
MACITENTAN—Oedema—Latanoprost—glaucoma	0.00269	0.0113	CcSEcCtD
MACITENTAN—Urinary tract infection—Dorzolamide—glaucoma	0.00269	0.0113	CcSEcCtD
MACITENTAN—Urinary tract infection—Travoprost—glaucoma	0.00268	0.0113	CcSEcCtD
MACITENTAN—Angiopathy—Bimatoprost—glaucoma	0.00267	0.0112	CcSEcCtD
MACITENTAN—Nervous system disorder—Latanoprost—glaucoma	0.00264	0.0111	CcSEcCtD
MACITENTAN—Pharyngitis—Brimonidine—glaucoma	0.00258	0.0109	CcSEcCtD
MACITENTAN—Urinary tract infection—Pilocarpine—glaucoma	0.00254	0.0107	CcSEcCtD
MACITENTAN—Pharyngitis—Dorzolamide—glaucoma	0.00247	0.0104	CcSEcCtD
MACITENTAN—Pharyngitis—Travoprost—glaucoma	0.00246	0.0103	CcSEcCtD
MACITENTAN—Pharyngitis—Brinzolamide—glaucoma	0.00243	0.0102	CcSEcCtD
MACITENTAN—Nasopharyngitis—Clonidine—glaucoma	0.00242	0.0102	CcSEcCtD
MACITENTAN—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00237	0.0111	CbGpPWpGaD
MACITENTAN—Angiopathy—Brimonidine—glaucoma	0.00236	0.00994	CcSEcCtD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00236	0.011	CbGpPWpGaD
MACITENTAN—Pharyngitis—Pilocarpine—glaucoma	0.00233	0.00981	CcSEcCtD
MACITENTAN—Angiopathy—Travoprost—glaucoma	0.00225	0.00945	CcSEcCtD
MACITENTAN—EDNRB—Endothelin Pathways—NOS3—glaucoma	0.00223	0.0104	CbGpPWpGaD
MACITENTAN—Angiopathy—Brinzolamide—glaucoma	0.00222	0.00933	CcSEcCtD
MACITENTAN—EDNRB—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.0022	0.0103	CbGpPWpGaD
MACITENTAN—EDNRA—G alpha (q) signalling events—OPN4—glaucoma	0.00218	0.0102	CbGpPWpGaD
MACITENTAN—EDNRB—Endothelins—EDN1—glaucoma	0.00218	0.0102	CbGpPWpGaD
MACITENTAN—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00216	0.0101	CbGpPWpGaD
MACITENTAN—Oedema—Apraclonidine—glaucoma	0.00215	0.00907	CcSEcCtD
MACITENTAN—Infection—Apraclonidine—glaucoma	0.00214	0.00901	CcSEcCtD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00212	0.00993	CbGpPWpGaD
MACITENTAN—Nervous system disorder—Apraclonidine—glaucoma	0.00211	0.00889	CcSEcCtD
MACITENTAN—Nasopharyngitis—Betaxolol—glaucoma	0.00211	0.00888	CcSEcCtD
MACITENTAN—Headache—Metipranolol—glaucoma	0.00208	0.00875	CcSEcCtD
MACITENTAN—Infection—Bimatoprost—glaucoma	0.00207	0.00873	CcSEcCtD
MACITENTAN—Nervous system disorder—Bimatoprost—glaucoma	0.00205	0.00862	CcSEcCtD
MACITENTAN—Influenza—Betaxolol—glaucoma	0.00204	0.00859	CcSEcCtD
MACITENTAN—Urinary tract infection—Clonidine—glaucoma	0.00203	0.00855	CcSEcCtD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00202	0.00945	CbGpPWpGaD
MACITENTAN—EDNRA—G alpha (q) signalling events—PTGFR—glaucoma	0.00197	0.00919	CbGpPWpGaD
MACITENTAN—Bronchitis—Betaxolol—glaucoma	0.00196	0.00826	CcSEcCtD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00195	0.00913	CbGpPWpGaD
MACITENTAN—Headache—Carteolol—glaucoma	0.00193	0.00811	CcSEcCtD
MACITENTAN—Headache—Diclofenamide—glaucoma	0.00189	0.00797	CcSEcCtD
MACITENTAN—Oedema—Brimonidine—glaucoma	0.00185	0.00778	CcSEcCtD
MACITENTAN—Headache—Carbachol—glaucoma	0.00185	0.00778	CcSEcCtD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00184	0.00863	CbGpPWpGaD
MACITENTAN—Infection—Brimonidine—glaucoma	0.00184	0.00773	CcSEcCtD
MACITENTAN—EDNRB—Endothelins—MMP1—glaucoma	0.00183	0.00857	CbGpPWpGaD
MACITENTAN—Headache—Levobunolol—glaucoma	0.00182	0.00766	CcSEcCtD
MACITENTAN—Infestation—Betaxolol—glaucoma	0.00182	0.00766	CcSEcCtD
MACITENTAN—Infestation NOS—Betaxolol—glaucoma	0.00182	0.00766	CcSEcCtD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00182	0.0085	CbGpPWpGaD
MACITENTAN—Nervous system disorder—Brimonidine—glaucoma	0.00181	0.00763	CcSEcCtD
MACITENTAN—Oedema—Dorzolamide—glaucoma	0.00177	0.00743	CcSEcCtD
MACITENTAN—EDNRA—GPCRs, Other—SMO—glaucoma	0.00176	0.00825	CbGpPWpGaD
MACITENTAN—Oedema—Travoprost—glaucoma	0.00176	0.0074	CcSEcCtD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.00176	0.00822	CbGpPWpGaD
MACITENTAN—Infection—Travoprost—glaucoma	0.00175	0.00735	CcSEcCtD
MACITENTAN—Headache—Methazolamide—glaucoma	0.00174	0.00734	CcSEcCtD
MACITENTAN—Hypotension—Brimonidine—glaucoma	0.00173	0.00727	CcSEcCtD
MACITENTAN—Infection—Brinzolamide—glaucoma	0.00172	0.00726	CcSEcCtD
MACITENTAN—Nervous system disorder—Travoprost—glaucoma	0.00172	0.00726	CcSEcCtD
MACITENTAN—Nasopharyngitis—Timolol—glaucoma	0.00172	0.00726	CcSEcCtD
MACITENTAN—Nervous system disorder—Brinzolamide—glaucoma	0.0017	0.00717	CcSEcCtD
MACITENTAN—Angiopathy—Clonidine—glaucoma	0.0017	0.00716	CcSEcCtD
MACITENTAN—Headache—Latanoprost—glaucoma	0.00169	0.0071	CcSEcCtD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00169	0.00789	CbGpPWpGaD
MACITENTAN—Oedema—Pilocarpine—glaucoma	0.00167	0.00702	CcSEcCtD
MACITENTAN—Infection—Pilocarpine—glaucoma	0.00166	0.00698	CcSEcCtD
MACITENTAN—Hypotension—Dorzolamide—glaucoma	0.00165	0.00695	CcSEcCtD
MACITENTAN—Hypotension—Travoprost—glaucoma	0.00164	0.00692	CcSEcCtD
MACITENTAN—Hypotension—Brinzolamide—glaucoma	0.00162	0.00683	CcSEcCtD
MACITENTAN—Pharyngitis—Betaxolol—glaucoma	0.00162	0.00682	CcSEcCtD
MACITENTAN—ALB—HDL-mediated lipid transport—ABCA1—glaucoma	0.0016	0.00747	CbGpPWpGaD
MACITENTAN—EDNRA—Endothelin Pathways—NOS3—glaucoma	0.00159	0.00746	CbGpPWpGaD
MACITENTAN—EDNRA—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.00157	0.00736	CbGpPWpGaD
MACITENTAN—EDNRA—Endothelins—EDN1—glaucoma	0.00156	0.0073	CbGpPWpGaD
MACITENTAN—Hypotension—Pilocarpine—glaucoma	0.00156	0.00656	CcSEcCtD
MACITENTAN—EDNRB—GPCR ligand binding—OPN4—glaucoma	0.00154	0.00719	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00152	0.0071	CbGpPWpGaD
MACITENTAN—Angiopathy—Betaxolol—glaucoma	0.00148	0.00624	CcSEcCtD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00145	0.00676	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—PTGFR—glaucoma	0.00138	0.00648	CbGpPWpGaD
MACITENTAN—Headache—Apraclonidine—glaucoma	0.00135	0.00568	CcSEcCtD
MACITENTAN—Oedema—Clonidine—glaucoma	0.00133	0.00561	CcSEcCtD
MACITENTAN—Infection—Clonidine—glaucoma	0.00132	0.00557	CcSEcCtD
MACITENTAN—Anaemia—Betaxolol—glaucoma	0.00131	0.00553	CcSEcCtD
MACITENTAN—EDNRA—Endothelins—MMP1—glaucoma	0.00131	0.00613	CbGpPWpGaD
MACITENTAN—Headache—Bimatoprost—glaucoma	0.00131	0.00551	CcSEcCtD
MACITENTAN—Nervous system disorder—Clonidine—glaucoma	0.00131	0.0055	CcSEcCtD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.0013	0.00609	CbGpPWpGaD
MACITENTAN—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.0013	0.00607	CbGpPWpGaD
MACITENTAN—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.00127	0.00593	CbGpPWpGaD
MACITENTAN—Hypotension—Clonidine—glaucoma	0.00125	0.00524	CcSEcCtD
MACITENTAN—Angiopathy—Timolol—glaucoma	0.00121	0.00509	CcSEcCtD
MACITENTAN—Headache—Acetazolamide—glaucoma	0.00121	0.00508	CcSEcCtD
MACITENTAN—Oedema—Betaxolol—glaucoma	0.00116	0.00488	CcSEcCtD
MACITENTAN—Headache—Brimonidine—glaucoma	0.00116	0.00488	CcSEcCtD
MACITENTAN—Infection—Betaxolol—glaucoma	0.00115	0.00485	CcSEcCtD
MACITENTAN—Nervous system disorder—Betaxolol—glaucoma	0.00114	0.00479	CcSEcCtD
MACITENTAN—Headache—Dorzolamide—glaucoma	0.00111	0.00466	CcSEcCtD
MACITENTAN—Headache—Travoprost—glaucoma	0.0011	0.00464	CcSEcCtD
MACITENTAN—EDNRA—GPCR ligand binding—OPN4—glaucoma	0.0011	0.00515	CbGpPWpGaD
MACITENTAN—CYP2C19—Tamoxifen metabolism—CYP1B1—glaucoma	0.0011	0.00513	CbGpPWpGaD
MACITENTAN—Headache—Brinzolamide—glaucoma	0.00109	0.00458	CcSEcCtD
MACITENTAN—Hypotension—Betaxolol—glaucoma	0.00108	0.00456	CcSEcCtD
MACITENTAN—ALB—HDL-mediated lipid transport—APOE—glaucoma	0.00105	0.00492	CbGpPWpGaD
MACITENTAN—Headache—Pilocarpine—glaucoma	0.00105	0.0044	CcSEcCtD
MACITENTAN—EDNRA—GPCR ligand binding—PTGFR—glaucoma	0.000991	0.00464	CbGpPWpGaD
MACITENTAN—Oedema—Timolol—glaucoma	0.000948	0.00399	CcSEcCtD
MACITENTAN—Infection—Timolol—glaucoma	0.000942	0.00396	CcSEcCtD
MACITENTAN—Nervous system disorder—Timolol—glaucoma	0.000929	0.00391	CcSEcCtD
MACITENTAN—ALB—Lipoprotein metabolism—ABCA1—glaucoma	0.000918	0.00429	CbGpPWpGaD
MACITENTAN—EDNRB—G alpha (q) signalling events—EDN1—glaucoma	0.000913	0.00427	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—EDN1—glaucoma	0.000901	0.00422	CbGpPWpGaD
MACITENTAN—Hypotension—Timolol—glaucoma	0.000886	0.00373	CcSEcCtD
MACITENTAN—EDNRB—GPCR downstream signaling—OPN4—glaucoma	0.000869	0.00406	CbGpPWpGaD
MACITENTAN—CYP2C19—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000847	0.00396	CbGpPWpGaD
MACITENTAN—Headache—Clonidine—glaucoma	0.000835	0.00351	CcSEcCtD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000817	0.00382	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—OPN4—glaucoma	0.000789	0.00369	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—C3—glaucoma	0.000787	0.00368	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—PTGFR—glaucoma	0.000783	0.00366	CbGpPWpGaD
MACITENTAN—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000746	0.00349	CbGpPWpGaD
MACITENTAN—Headache—Betaxolol—glaucoma	0.000727	0.00306	CcSEcCtD
MACITENTAN—EDNRB—Signaling by GPCR—PTGFR—glaucoma	0.000711	0.00332	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—SMO—glaucoma	0.000698	0.00327	CbGpPWpGaD
MACITENTAN—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	0.000685	0.0032	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—LRP12—glaucoma	0.000673	0.00315	CbGpPWpGaD
MACITENTAN—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000659	0.00308	CbGpPWpGaD
MACITENTAN—EDNRA—G alpha (q) signalling events—EDN1—glaucoma	0.000653	0.00306	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—EDN1—glaucoma	0.000645	0.00302	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—TXN—glaucoma	0.000628	0.00294	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—OPN4—glaucoma	0.000622	0.00291	CbGpPWpGaD
MACITENTAN—ALB—Lipid and lipoprotein metabolism—ABCA1—glaucoma	0.00061	0.00285	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000605	0.00283	CbGpPWpGaD
MACITENTAN—ALB—Lipoprotein metabolism—APOE—glaucoma	0.000604	0.00282	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—ABCA1—glaucoma	0.0006	0.00281	CbGpPWpGaD
MACITENTAN—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000596	0.00279	CbGpPWpGaD
MACITENTAN—Headache—Timolol—glaucoma	0.000594	0.0025	CcSEcCtD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000584	0.00273	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—OPN4—glaucoma	0.000565	0.00264	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—C3—glaucoma	0.000564	0.00264	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—PTGFR—glaucoma	0.00056	0.00262	CbGpPWpGaD
MACITENTAN—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	0.000557	0.0026	CbGpPWpGaD
MACITENTAN—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000548	0.00256	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—SOD1—glaucoma	0.000535	0.0025	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000528	0.00247	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—PTGFR—glaucoma	0.000509	0.00238	CbGpPWpGaD
MACITENTAN—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—glaucoma	0.0005	0.00234	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—SMO—glaucoma	0.0005	0.00234	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—TGFB2—glaucoma	0.000493	0.0023	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—ABCA1—glaucoma	0.000489	0.00228	CbGpPWpGaD
MACITENTAN—ALB—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000482	0.00225	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—LRP12—glaucoma	0.000481	0.00225	CbGpPWpGaD
MACITENTAN—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000473	0.00221	CbGpPWpGaD
MACITENTAN—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—glaucoma	0.00047	0.0022	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—glaucoma	0.000469	0.00219	CbGpPWpGaD
MACITENTAN—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000467	0.00218	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—OPN4—glaucoma	0.000466	0.00218	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—EDN1—glaucoma	0.00046	0.00215	CbGpPWpGaD
MACITENTAN—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000448	0.0021	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—SOD1—glaucoma	0.000435	0.00204	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—HEYL—glaucoma	0.000434	0.00203	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000433	0.00202	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—MTHFR—glaucoma	0.000424	0.00198	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PTGFR—glaucoma	0.00042	0.00196	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—C3—glaucoma	0.000402	0.00188	CbGpPWpGaD
MACITENTAN—ALB—Lipid and lipoprotein metabolism—APOE—glaucoma	0.000401	0.00188	CbGpPWpGaD
MACITENTAN—ALB—Lipid and lipoprotein metabolism—CAV1—glaucoma	0.000398	0.00186	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—APOE—glaucoma	0.000395	0.00185	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—ABCA1—glaucoma	0.000388	0.00181	CbGpPWpGaD
MACITENTAN—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000384	0.00179	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000378	0.00177	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—SOD1—glaucoma	0.000373	0.00175	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—PEX19—glaucoma	0.000363	0.0017	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—SMO—glaucoma	0.000358	0.00168	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—glaucoma	0.000356	0.00166	CbGpPWpGaD
MACITENTAN—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000352	0.00165	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—SOD1—glaucoma	0.000346	0.00162	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—MTHFR—glaucoma	0.000345	0.00161	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—OPN4—glaucoma	0.000334	0.00156	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—EDN1—glaucoma	0.00033	0.00154	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—RPTOR—glaucoma	0.000329	0.00154	CbGpPWpGaD
MACITENTAN—ALB—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000322	0.0015	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NCK2—glaucoma	0.000318	0.00149	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—HEYL—glaucoma	0.00031	0.00145	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PTGFR—glaucoma	0.0003	0.00141	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—C3—glaucoma	0.000288	0.00135	CbGpPWpGaD
MACITENTAN—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000285	0.00133	CbGpPWpGaD
MACITENTAN—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000281	0.00131	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—MTHFR—glaucoma	0.000274	0.00128	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—HDAC9—glaucoma	0.000271	0.00127	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—EDN1—glaucoma	0.00026	0.00122	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—FN1—glaucoma	0.00026	0.00121	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—SMO—glaucoma	0.000256	0.0012	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—GSTT1—glaucoma	0.000256	0.0012	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	0.000248	0.00116	CbGpPWpGaD
MACITENTAN—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	0.000247	0.00115	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000245	0.00115	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—EDN1—glaucoma	0.000236	0.0011	CbGpPWpGaD
MACITENTAN—ALB—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000235	0.0011	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—RPTOR—glaucoma	0.000235	0.0011	CbGpPWpGaD
MACITENTAN—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000231	0.00108	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NCK2—glaucoma	0.000228	0.00106	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—C3—glaucoma	0.000227	0.00106	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.000219	0.00102	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000212	0.000992	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—SMO—glaucoma	0.000212	0.00099	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—C3—glaucoma	0.000206	0.000965	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—CYP1B1—glaucoma	0.000204	0.000953	CbGpPWpGaD
MACITENTAN—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	0.000201	0.00094	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—NARFL—glaucoma	0.0002	0.000934	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CA5A—glaucoma	0.0002	0.000934	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NTRK2—glaucoma	0.000194	0.000905	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—HDAC9—glaucoma	0.000194	0.000905	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.00019	0.00089	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—EDN1—glaucoma	0.000186	0.000871	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—TNF—glaucoma	0.000183	0.000854	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CA5A—glaucoma	0.000179	0.000838	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—NARFL—glaucoma	0.000179	0.000838	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—PTGS2—glaucoma	0.000175	0.000818	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—EDN1—glaucoma	0.000169	0.000791	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NGFR—glaucoma	0.000166	0.000777	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—SOD1—glaucoma	0.000166	0.000774	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000163	0.000764	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—GSTM1—glaucoma	0.000163	0.000762	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—C3—glaucoma	0.000163	0.000761	CbGpPWpGaD
MACITENTAN—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	0.000161	0.000751	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NTRK1—glaucoma	0.000158	0.000738	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—GSTT1—glaucoma	0.000154	0.000719	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—SMO—glaucoma	0.000152	0.000709	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—VEGFA—glaucoma	0.000149	0.000695	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—TNF—glaucoma	0.000149	0.000695	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—C3—glaucoma	0.000148	0.000691	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CDKN2B—glaucoma	0.000145	0.00068	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	0.000142	0.000662	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—EDN1—glaucoma	0.00014	0.000653	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NTRK2—glaucoma	0.000139	0.000648	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—TP53—glaucoma	0.000131	0.000613	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NGF—glaucoma	0.000128	0.0006	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—CYP1B1—glaucoma	0.000123	0.000573	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—C3—glaucoma	0.000122	0.00057	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	0.000121	0.000565	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.00012	0.000559	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NGFR—glaucoma	0.000119	0.000556	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—TNF—glaucoma	0.000118	0.000552	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	0.000115	0.000539	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—APOE—glaucoma	0.000114	0.000531	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NTRK1—glaucoma	0.000113	0.000528	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—TGFB2—glaucoma	0.000113	0.000527	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CAV1—glaucoma	0.000112	0.000526	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—NARFL—glaucoma	0.000108	0.000504	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CA5A—glaucoma	0.000108	0.000504	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—FN1—glaucoma	0.000107	0.000501	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—BAD—glaucoma	0.000106	0.000495	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CDKN2B—glaucoma	0.000104	0.000487	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—EDN1—glaucoma	9.99e-05	0.000467	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—GSTM1—glaucoma	9.8e-05	0.000458	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CA1—glaucoma	9.75e-05	0.000456	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	9.66e-05	0.000452	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CTSA—glaucoma	9.45e-05	0.000442	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NGF—glaucoma	9.18e-05	0.000429	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CA2—glaucoma	8.92e-05	0.000417	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CA1—glaucoma	8.76e-05	0.000409	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—C3—glaucoma	8.73e-05	0.000408	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	8.72e-05	0.000408	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	8.72e-05	0.000408	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—SOD1—glaucoma	8.54e-05	0.000399	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NOS3—glaucoma	8.5e-05	0.000398	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CTSA—glaucoma	8.48e-05	0.000397	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—APOE—glaucoma	8.12e-05	0.00038	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CAV1—glaucoma	8.05e-05	0.000376	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CA2—glaucoma	8.01e-05	0.000374	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.83e-05	0.000366	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.83e-05	0.000366	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—FN1—glaucoma	7.66e-05	0.000358	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—BAD—glaucoma	7.57e-05	0.000354	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CDKN1B—glaucoma	7.37e-05	0.000344	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MMP9—glaucoma	6.82e-05	0.000319	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	6.6e-05	0.000308	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—MMP1—glaucoma	6.51e-05	0.000304	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—TXN—glaucoma	6.28e-05	0.000294	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—CAV1—glaucoma	6.24e-05	0.000292	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—VEGFA—glaucoma	6.13e-05	0.000287	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NOS3—glaucoma	6.09e-05	0.000285	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—FN1—glaucoma	5.94e-05	0.000278	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	5.73e-05	0.000268	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	5.68e-05	0.000266	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—TXN—glaucoma	5.64e-05	0.000264	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CDKN1B—glaucoma	5.27e-05	0.000247	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CA1—glaucoma	5.26e-05	0.000246	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	5.15e-05	0.000241	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	5.1e-05	0.000239	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CTSA—glaucoma	5.1e-05	0.000238	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MMP9—glaucoma	4.88e-05	0.000228	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GSTT1—glaucoma	4.87e-05	0.000228	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CA2—glaucoma	4.82e-05	0.000225	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—NOS3—glaucoma	4.72e-05	0.000221	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TP53—glaucoma	4.63e-05	0.000216	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—VEGFA—glaucoma	4.39e-05	0.000205	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GSTT1—glaucoma	4.37e-05	0.000205	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.93e-05	0.000184	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ABCA1—glaucoma	3.88e-05	0.000182	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYP1B1—glaucoma	3.88e-05	0.000182	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.53e-05	0.000165	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYP1B1—glaucoma	3.49e-05	0.000163	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ABCA1—glaucoma	3.49e-05	0.000163	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—VEGFA—glaucoma	3.4e-05	0.000159	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—TXN—glaucoma	3.39e-05	0.000159	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TP53—glaucoma	3.31e-05	0.000155	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GSTM1—glaucoma	3.1e-05	0.000145	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GSTM1—glaucoma	2.79e-05	0.00013	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—MTHFR—glaucoma	2.74e-05	0.000128	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GSTT1—glaucoma	2.63e-05	0.000123	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—TP53—glaucoma	2.57e-05	0.00012	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—APOE—glaucoma	2.55e-05	0.000119	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CAV1—glaucoma	2.53e-05	0.000118	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—MTHFR—glaucoma	2.46e-05	0.000115	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—APOE—glaucoma	2.29e-05	0.000107	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CAV1—glaucoma	2.27e-05	0.000106	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ABCA1—glaucoma	2.1e-05	9.8e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYP1B1—glaucoma	2.1e-05	9.8e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—NOS3—glaucoma	1.91e-05	8.95e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PTGS2—glaucoma	1.75e-05	8.18e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—NOS3—glaucoma	1.72e-05	8.03e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GSTM1—glaucoma	1.68e-05	7.84e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PTGS2—glaucoma	1.57e-05	7.35e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—MTHFR—glaucoma	1.48e-05	6.92e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—APOE—glaucoma	1.38e-05	6.45e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CAV1—glaucoma	1.37e-05	6.39e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—NOS3—glaucoma	1.03e-05	4.83e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PTGS2—glaucoma	9.45e-06	4.42e-05	CbGpPWpGaD
